Your browser doesn't support javascript.
loading
Heart Rate Variability and the Efficacy of Biofeedback in Heroin Users with Depressive Symptoms
Article in English | WPRIM (Western Pacific) | ID: wpr-25925
Responsible library: WPRO
ABSTRACT

OBJECTIVE:

Low heart rate variability (HRV) has been confirmed in heroin users, but the effects of heart-rate-variability-biofeedback in heroin users remain unknown. This study examined (1) correlations between depression and HRV indices; (2) group differences in HRV indices among a heroin-user group, a group with major depressive disorder but no heroin use, and healthy controls; and (3) the effects of heart-rate-variability-biofeedback on depressive symptoms, HRV indices, and respiratory rates within the heroin group.

METHODS:

All participants completed a depression questionnaire and underwent electrocardiogram measurements, and group differences in baseline HRV indices were examined. The heroin group underwent electrocardiogram and respiration rate measurements at baseline, during a depressive condition, and during a happiness condition, before and after which they took part in the heart-rate-variability-biofeedback program. The effects of heart-rate-variability-biofeedback on depressive symptoms, HRV indices, and respiration rates were examined.

RESULTS:

There was a negative correlation between depression and high frequency of HRV, and a positive correlation between depression and low frequency to high frequency ratio of HRV. The heroin group had a lower overall and high frequency of HRV, and a higher low frequency/high frequency ratio than healthy controls. The heart-rate-variability-biofeedback intervention increased HRV indices and decreased respiratory rates from pre-intervention to post-intervention.

CONCLUSION:

Reduced parasympathetic and increased sympathetic activations were found in heroin users. Heart-rate-variability-biofeedback was an effective non-pharmacological intervention to restore autonomic balance.
Subject(s)

Full text: Available Health context: SDG3 - Health and Well-Being / SDG3 -Target 3.5 Prevention and treatment of consumption of psychoactive substances Health problem: Target 3.5: Prevention and treatment of consumption of psychoactive substances / Opioid Abuse Database: WPRIM (Western Pacific) Main subject: Autonomic Nervous System / Biofeedback, Psychology / Depression / Depressive Disorder, Major / Heroin / Electrocardiography / Respiratory Rate / Happiness / Heart / Heart Rate Type of study: Diagnostic study Language: English Journal: Clinical Psychopharmacology and Neuroscience Year: 2016 Document type: Article
Full text: Available Health context: SDG3 - Health and Well-Being / SDG3 -Target 3.5 Prevention and treatment of consumption of psychoactive substances Health problem: Target 3.5: Prevention and treatment of consumption of psychoactive substances / Opioid Abuse Database: WPRIM (Western Pacific) Main subject: Autonomic Nervous System / Biofeedback, Psychology / Depression / Depressive Disorder, Major / Heroin / Electrocardiography / Respiratory Rate / Happiness / Heart / Heart Rate Type of study: Diagnostic study Language: English Journal: Clinical Psychopharmacology and Neuroscience Year: 2016 Document type: Article
...